EXECUTIVE SUMMARY  The Health Intervention and Technology Assessment Program Foundation (HITAP), Thailand, undertook a mission to Colombo, Sri Lanka, supported by the World Bank Group. The mission aimed to support national efforts to strengthen capacity on health priority setting and institutiona

Abstract Understanding the financial and health consequences if economic evaluation assumptions prove incorrect is essential for managing the risk associated with benefit package decisions, particularly in resource-constrained and overburdened healthcare systems. Yet these are also the settings t

Background Target Product Profiles (TPPs) serve as strategic tools for planning medical innovation development, facilitating communication with regulators, and developing market access strategies. Modelling can assist TPPs development and provide guidance on defining attributes. This scoping re

การพัฒนานวัตกรรมทางการแพทย์เป็นยุทธศาสตร์สำคัญของประเทศไทยภายใต้แผนพัฒนาเศรษฐกิจและสังคมแห่งชาติ ฉบับที่ 13 เพื่อยกระดับ

Executive summary A visit was conducted to Mwanza, Tanzania from 17 to 18 February 2026 to participate in the Stakeholders Workshop on the Launching of the Delivery of arpraziquantel (arPZQ) in Tanzania. The workshop was organised by the National Institute for Medical Research (NIMR), the nationa

Executive Summary The 4th Regional Workshop on Advanced Economic Evaluation was held on 23–25 February 2026 at Jawaharlal Institute of Postgraduate Medical Education & Research (JIPMER) in Puducherry, India. The workshop was co-organized by JIPMER, the Saw Swee Hock School of Public Health, N

This report examines global experiences in coordinated procurement of health technologies and explores their potential application for antibiotics in ASEAN. Drawing on a scoping review and stakeholder consultations, it analyses key determinants—including governance, financing, regulatory systems, an

Digital health technologies (e.g., wearables, electronic health records, and artificial intelligence tools) are increasingly recognized for their potential to enhance care quality, efficiency, and reach of healthcare services while potentially reducing costs [1]. Landscape reviews have shown increasing investments by governments and other stakehold

Achieving universal access to essential healthcare products remains a critical challenge across low- and middle-income countries (LMICs). While individual countries may have made notable strides in strengthening their procurement and regulatory systems, regional disparities in access, affordability,

Traditional and complementary medicines (T&CM) have increased in uptake and economic importance globally. T&CM involves the examination, diagnosis, therapy, treatment, disease prevention, and rehabilitation. The World Health Organization\'s (WHO) Traditional Medicine Strategy 2014-2023 outlines a framework for action through the regulation,